Pendergrass JC, Targum SD, Harrison JE. Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci. 2018;15(1–2):36–44.

PubMed  PubMed Central  Google Scholar 

Ibrar M, Rai HK, Main A, McCartney H, Maguire R, Rodriguez MAP. The experience of cancer-related cognitive impairment across common cancers: protocol for a qualitative systematic review. JMIR Res Protoc. 2024;13: e56888.

Article  PubMed  PubMed Central  Google Scholar 

Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925–40.

Article  CAS  PubMed  Google Scholar 

Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 2005;11(6):437–41.

Article  PubMed  Google Scholar 

Kanaskie ML, Loeb SJ. The experience of cognitive change in women with breast cancer following chemotherapy. J Cancer Surviv. 2015;9(3):375–87.

Article  PubMed  Google Scholar 

Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012;79(15):1591.

Article  PubMed  PubMed Central  Google Scholar 

Avila-Villanueva M, Avila J. Reversion or compensation of mild cognitive impairment to normal cognition: strategies to prevent the development of Alzheimer’s disease continuum. Open Explor. 2024;4(5):392–400.

Google Scholar 

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–35.

Article  PubMed  PubMed Central  Google Scholar 

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.

Article  PubMed  Google Scholar 

Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322(16):1589–99.

Article  PubMed  PubMed Central  Google Scholar 

Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018;5(14):425.

Article  Google Scholar 

Fernandes HA, Richard NM, Edelstein K. Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review. Support Care Cancer. 2019;27(9):3253–79.

Article  PubMed  Google Scholar 

Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102–13.

Article  PubMed  PubMed Central  Google Scholar 

Loh KP, Janelsins MC, Mohile SG, Holmes HM, Hsu T, Inouye SK, et al. Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol. 2016;7(4):270–80.

Article  PubMed  PubMed Central  Google Scholar 

Dos Santos M, Licaj I, Bellera C, Cany L, Binarelli G, Soubeyran P, et al. Cognitive impairment in older cancer patients treated with first-line chemotherapy. Cancers (Basel). 2021;13(24):6171.

Article  PubMed  Google Scholar 

Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267–75.

Article  CAS  PubMed  Google Scholar 

Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, et al. Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the thinking and living with cancer study. J Clin Oncol. 2023;41(2):295–306.

Article  CAS  PubMed  Google Scholar 

Országhová Z, Mego M, Chovanec M. Long-term cognitive dysfunction in cancer survivors. Front Mol Biosci. 2021;14:8.

Google Scholar 

Downie FP, Mar Fan HG, Houédé-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology. 2006;15(10):921–30.

Article  PubMed  Google Scholar 

Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med. 2013;29(4):873–93.

Article  PubMed  PubMed Central  Google Scholar 

Peters ME, Rosenberg PB, Steinberg M, Tschanz JT, Norton MC, Welsh-Bohmer KA, et al. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the cache county study. Am J Geriatr Psychiatry. 2012;20(5):416.

Article  PubMed  PubMed Central  Google Scholar 

Lyketsos CG, Colenda CC, Beck C, Blank K, Doraiswamy MP, Kalunian DA, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry. 2006;14(7):561–73.

Article  PubMed  Google Scholar 

Martín BR, Rodríguez EJF, Galve MIR, Hernández JJC. Study of chemotherapy-induced cognitive impairment in women with breast cancer. Int J Environ Res Public Health. 2020;17(23):1–13.

Google Scholar 

Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med. 2014;30(3):421.

Article  PubMed  PubMed Central  Google Scholar 

Battisti NML, Joshi K, Nasser MS, Ring A. Systemic therapy for older patients with early breast cancer. Cancer Treat Rev. 2021;1:100.

Google Scholar 

Biganzoli L, Battisti NML, Wildiers H, McCartney A, Colloca G, Kunkler IH, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG). Lancet Oncol. 2021;22(7):e327–40.

Article  PubMed  Google Scholar 

Haggstrom LR, Vardy JL, Carson EK, Segara D, Lim E, Kiely BE. Effects of endocrine therapy on cognitive function in patients with breast cancer: a comprehensive review. Cancers (Basel). 2022;14(4):920.

Article  CAS  PubMed  Google Scholar 

Nelson CJ, Lee JS, Gamboa MC, Roth AJ. cognitive effects of hormone therapy in men with prostate cancer. Cancer. 2008;113(5):1097.

Article  CAS  PubMed  Google Scholar 

Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26(7):955–69.

Article  PubMed  Google Scholar 

Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause. 2007;14(6):995–8.

Article  PubMed  PubMed Central  Google Scholar 

Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, et al. Cancer-related cognitive outcomes among older breast cancer survivors in the Thinking and Living with Cancer study. J Clin Oncol. 2018;36(32):3211–22.

Article  CAS  PubMed Central  Google Scholar 

Phillips KA, Aldridge J, Ribi K, Sun Z, Thompson A, Harvey V, et al. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1–98 trial. Breast Cancer Res Treat. 2011;126(1):221–6.

Article  CAS  PubMed  Google Scholar 

Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol. 2010;28(8):1294–300.

Article  CAS  PubMed  Google Scholar 

McDonald BC, Saykin AJ. Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations. Brain Imaging Behav. 2013;7(4):374–87.

Article  PubMed